Company Directory - Operation Warp Speed
Company Details - Operation Warp Speed
Operation Warp Speed
A public-private partnership initiated by the United States government to facilitate and accelerate the development of COVID-19 vaccines and treatments.
CCI Score
CCI Score: Operation Warp Speed
10.44
Latest Event
Operation Warp Speed and Vaccine Nationalism
The article details how Operation Warp Speed allocated US$18 billion to accelerate vaccine development with a strong US focus, an approach that has been criticized for fueling vaccine nationalism and undermining global vaccine equity.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
SABOTEUR
Operation Warp Speed is currently rated as a Saboteur.
Latest Events
- MAR262021
The article details how Operation Warp Speed allocated US$18 billion to accelerate vaccine development with a strong US focus, an approach that has been criticized for fueling vaccine nationalism and undermining global vaccine equity.
-60
Public and Political Behavior
March 29
Operation Warp Speed’s strategy prioritized domestic vaccine needs at the expense of a coordinated global response, reflecting a nationalist stance that undermines international cooperation and equitable access, which is concerning from an anti-authoritarian and global solidarity perspective.
Operation Warp Speed: implications for global vaccine security
-40
Economic and Structural Influence
March 29
The program’s economic arrangements and procurement strategies, which favored domestic agreements and prioritized US needs, have reinforced structural inequities in global vaccine distribution, limiting access for low- and middle-income countries.
Operation Warp Speed: implications for global vaccine security
- MAR202021
The article reviews how Operation Warp Speed, initiated under the Trump administration, successfully accelerated COVID-19 vaccine development, manufacturing, and distribution by making early large-scale vaccine purchases and parallelizing clinical trials and production, ultimately meeting or exceeding its ambitious targets.
+50
Public and Political Behavior
March 29
Under Public and Political Behavior, Operation Warp Speed used bold government-private partnerships to fast‐track vaccine development in a time of crisis. Despite its origin under the Trump administration—which some critics associated with authoritarian tendencies—the program’s decisive actions significantly supported public health measures, a move that is seen positively from an anti‑fascist perspective that values life-saving initiatives.
+40
Business Practices and Ethical Responsibility
March 29
Within the scope of Business Practices and Ethical Responsibility, the program exemplified effective public‑private collaboration under high pressure. Early financial commitments and risk‐taking in purchasing vaccine doses before approvals reflected responsible business practices aimed at safeguarding public health.
+40
Technology and Services Impact
March 29
In terms of Technology and Services Impact, Operation Warp Speed leveraged innovative approaches by running parallel clinical trials and manufacturing processes. This contributed to rapid regulatory approval and efficient vaccine rollout, which had wide-reaching positive effects on public health.
+30
Economic and Structural Influence
March 29
For Economic and Structural Influence, the program’s significant financial investments and restructuring of vaccine production timelines represented a bold reconfiguration of traditional economic practices in public health emergencies. Although initiated by a polarizing administration, the structural changes promoted rapid scaling and wider access to vaccines, aligning with broader progressive interests in public welfare.
- JAN302021
The GAO report details how Operation Warp Speed, a public-private partnership between HHS and DOD, accelerated COVID-19 vaccine development through innovative strategies in clinical trials and manufacturing partnerships, while addressing supply chain and workforce challenges.
+60
Public and Political Behavior
March 29
Operation Warp Speed demonstrated strong public and political engagement by fostering collaboration between government agencies and private vaccine manufacturers to expedite vaccine development, a measure that supports public health and counters authoritarian mismanagement.
+40
Technology and Services Impact
March 29
The initiative leveraged advanced vaccine platform technologies and streamlined clinical trials to accelerate readiness, showcasing significant technological impact in public health.
+20
Economic and Structural Influence
March 29
Efforts to overcome manufacturing bottlenecks, including partnerships to expand production capacity and streamline supply chains, reflect positive economic and structural influence that supports broad public welfare.
- NOV192020
The article details how Operation Warp Speed facilitated major funding deals with vaccine developers such as Pfizer, Moderna, Johnson & Johnson, and others. The initiative helped expedite the research, development, and manufacturing of COVID-19 vaccines, while receiving high-profile political endorsements and credit from figures like President Donald Trump.
+70
Public and Political Behavior
March 29
Operation Warp Speed, despite being entwined with politicized credit-taking from the Trump administration, is primarily a government-led public-private partnership that has aimed to rapidly deliver vaccines to the public. Its public and political behavior promotes a significant public health initiative.
+80
Technology and Services Impact
March 29
By supporting rapid vaccine research and manufacturing processes, Operation Warp Speed has significantly impacted technological and service-related advancements in healthcare. This accelerated approach to vaccine development has improved public health outcomes.
+50
Economic and Structural Influence
March 29
The initiative structured large-scale economic agreements with multiple pharmaceutical companies, facilitating unprecedented funding and manufacturing capacities. This economic and structural influence contributed to the accelerated distribution of vaccines across the nation.
- APR292020
Operation Warp Speed, launched in early reports around April 29, 2020 and officially announced on May 15, 2020 by the Trump administration, accelerated COVID‑19 vaccine development. Its leadership, marked by controversial appointments and conflicts of interest—most notably the case of Moncef Slaoui and his ties to Moderna—raised concerns about the intertwining of public health policy with partisan political motivations and authoritarian overtones.
-20
Executive Political Engagement
March 29
The initiative was directly shaped by political imperatives under the Trump administration, using executive actions to fast‐track vaccine development. The politically charged environment and leadership conflicts, including the controversial involvement and subsequent resignation of Moncef Slaoui due to potential conflicts of interest, suggest an entanglement with partisan, authoritarian modes of engagement. This raises ethical concerns about executive political engagement and the blurring of public health policy with political agendas.
Alternatives
Corporation
54.23
Corporation
-26.78
New York, United States
14.83
Glendale, United States
0.00
Bethesda, United States
-11.29
Hangzhou, China
-31.95
Sunnyvale, United States
-39.38
Abbott Park, United States
-41.78
McLean, United States
-62.66
Corporation
41.77
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541512
- Computer Systems Design Services
- 541990
- All Other Professional, Scientific, and Technical Services
- 621511
- Medical Laboratories
- 541711
- Research and Development in Biotechnology